Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessment.
Estrella-Porter P, Blanco-Calvo C, Lameiras-Azevedo AS, Juaneda J, Fernández-Martínez S, Gómez-Pajares F, Tempelsman R, Roig-Sena FJ, Pérez-Panades J, Botella-Rocamora P, Lluch-Rodrigo JA, Pastor-Villalba E.
Estrella-Porter P, et al. Among authors: fernandez martinez s.
Vaccine. 2024 Jun 3:S0264-410X(24)00657-1. doi: 10.1016/j.vaccine.2024.05.078. Online ahead of print.
Vaccine. 2024.
PMID: 38834430